Oligopeptide signaling through TbGPR89 drives trypanosome quorum sensing
MetadataShow full item record
Trypanosome parasites control their virulence and spread by using quorum sensing (QS) to generate transmissible “stumpy forms” in their host bloodstream. However, the QS signal “stumpy induction factor” (SIF) and its reception mechanism are unknown. Although trypanosomes lack G protein-coupled receptor signaling, we have identified a surface GPR89-family protein that regulates stumpy formation. TbGPR89 is expressed on bloodstream “slender form” trypanosomes, which receive the SIF signal, and when ectopically expressed, TbGPR89 drives stumpy formation in a SIF-pathway-dependent process. Structural modeling of TbGPR89 predicts unexpected similarity to oligopeptide transporters (POT), and when expressed in bacteria, TbGPR89 transports oligopeptides. Conversely, expression of an E. coli POT in trypanosomes drives parasite differentiation, and oligopeptides promote stumpy formation in vitro. Furthermore, the expression of secreted trypanosome oligopeptidases generates a paracrine signal that accelerates stumpy formation in vivo. Peptidase-generated oligopeptide QS signals being received through TbGPR89 provides a mechanism for both trypanosome SIF production and reception.
Rojas , F , Silvester , E , Young , J , Milne , R , Tettey , M , Houston , D R , Walkinshaw , M D , Pérez-Pi , I , Auer , M , Denton , H , Smith , T K , Thompson , J & Matthews , K R 2018 , ' Oligopeptide signaling through Tb GPR89 drives trypanosome quorum sensing ' Cell , vol. 176 , no. 1-2 , e16 , pp. 306-317 . https://doi.org/10.1016/j.cell.2018.10.041
Copyright 2018 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
DescriptionK.R.M. is funded by a Wellcome Trust Investigator Award (103740/Z14/Z) and a Royal Society Wolfson Research merit award (WM140045). The Medical Research Council (MR/M020118/1) supported T.K.S., and the Wellcome Trust supported J.T. (202094/Z/16/Z). M.A. received financial support from the Scottish Universities Life Sciences Alliance (SULSA; https://www.sulsa.ac.uk) and a Medical Research Council strategic grant (J54359).
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.